Report Description

Australia microfluidics market is anticipated to undergo significant growth during the forecast period, 2024-2028. The rising penetration of microfluidics devices in numerous fields of research and diagnosis along with rising incidence of chronic diseases are expected to facilitate the growth of the market. For instances, in 2022, the University of Technology Sydney (UTS), Australia has developed a 3D printed system for harvesting stem cells from bioreactors. The technology uses 3D printing and microfluidics to integrate several production steps into one device that can help make stem cell therapies more widely available to patients at a lower cost. The well-established healthcare system and better reimbursement policies in the country are bolstering the growth of the market. Besides, the other factors which are supporting the growth are the evolution of advanced lab-on-a-chip technologies, growing demand for point-of-care testing and adoption of high-throughput screening methodologies.

Microfluids are widely used in DNA analysis, cell patterning and separation & manipulation of cells. They are also used in research for the study of antibiotic drug-resistant bacteria. Furthermore, wide application of microfluidics in tissue engineering, pathogen detection in human/animals and point-of-care analysis are expected to act as major growth drivers for Australia microfluidics market.

Australia microfluidics market is segmented into product type, material, application, end user and region. Based on application, the market is categorized into in vitro diagnostics, pharmaceutical & life science research & manufacturing, and therapeutics. Among them, the in vitro diagnostics segment is expected to dominate the market during the forecast period. This is attributed to the high demand for point-of-care testing in Australia. Also, the rising occurrences of target diseases, along with increasing demand for PoC testing are anticipated to augment the growth of the market in upcoming years.  

Major companies operating in Australia microfluidics market include MTPConnect, SCHOTT AG, Microfluidics Biomedical Pty. Ltd., SDR Scientific Pty Ltd, WHITE RABBIT SCIENTIFIC LIMITED, Australian National Fabrication Facility, AI Fluidics PTY LTD, Merck Pty. Ltd., and Thermo Fisher Scientific Inc. Leading companies are adopting growth strategies like new product launches and mergers & acquisitions to enhance their market presence.

Objective of the Study:

  • To analyze and forecast the market size of Australia microfluidics market.
  • To forecast Australia microfluidics market based on component type, material, application, sector, end user, company and regional distribution.
  • To identify drivers and challenges for Australia microfluidics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in Australia microfluidics market.
  • To identify and analyze the profile of leading players operating in the Australia microfluidics market.

Download Free Sample Report

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of microfluidic manufacturing companies across Australia. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated Australia microfluidics market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Microfluidic manufacturers, companies, partners, and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to microfluidics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as microfluidic manufacturing companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.



Base Year


Historical Data

2018 – 2021

Estimated Year


Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F

Report coverage

Revenue forecast, Company share, Competitive landscape, Growth factors, and Trends

Segments covered

·         Product Type

·         Material

·         Application

·         End User

·         Region

Regional scope

New South Wales, Victoria, Queensland, Tasmania, Northern Territory, Western Australia, South Australia

Key companies profiled

MTPConnect, SCHOTT AG, Microfluidics Biomedical Pty. Ltd., SDR Scientific Pty Ltd, WHITE RABBIT SCIENTIFIC LIMITED, Australian National Fabrication Facility, AI Fluidics PTY LTD, Merck Pty. Ltd., and Thermo Fisher Scientific Inc..

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Australia microfluidics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Australia Microfluidics Market, By Product Type:
    • Microfluidic Based Devices
    • Microfluidic Components

·         Australia Microfluidics Market, By Material:

    • Glass
    • Silicon
    • Polymers
    • Others
  • Australia Microfluidics Market, By Application:
    • In Vitro diagnostics
    • Pharmaceutical & Life Science Research & Manufacturing
    • Therapeutics
  • Australia Microfluidics Market, By End User:
    • Hospitals & Diagnostic Centers
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Australia Microfluidics Market, By Region:
    • New South Wales
    • Victoria
    • Queensland
    • Western Australia
    • South Australia
    • Tasmania
    • Northern Territory

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Australia microfluidics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Australia Microfluidics Market Outlook

5.1.  Market Size & Forecast

5.1.1. By Value

5.2.  Market Share & Forecast

5.2.1. By Product Type (Microfluidic Based Devices v/s Microfluidic Components)

5.2.2. By Material (Glass, Silicon, Polymers, Others)

5.2.3. By Application (In-vitro Diagnostics, Pharmaceutical & Life Science Research & Manufacturing, Therapeutics)

5.2.4. By End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)

5.2.5. By Region

5.2.6. By Company (2022)

5.3.  Market Map

5.3.1.     By Product Type

5.3.2.     By Material

5.3.3.     By Application

5.3.4.     By End User

5.3.5.     By Region

6.    Australia Microfluidic Based Devices Market Outlook

6.1.  Market Size & Forecast          

6.1.1. By Value

6.2.  Market Share & Forecast

6.2.1. By Material

6.2.2. By Application

6.2.3. By End User

7.    Australia Microfluidic Components Market Outlook

7.1.  Market Size & Forecast          

7.1.1. By Value

7.2.  Market Share & Forecast

7.2.1. By Material

7.2.2. By Application

7.2.3. By End User

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

11.  Australia Economic Profile

12.  Competitive Landscape

12.1.              Business Overview

12.2.              Product Offerings

12.3.              Recent Developments

12.4.              Financials (As Reported)

12.5.              Key Personnel

12.6.              SWOT Analysis

12.6.1.   MTPConnect

12.6.2.   SCHOTT AG

12.6.3.   Microfluidics Biomedical Pty. Ltd.

12.6.4.   SDR Scientific Pty Ltd


12.6.6.   Australian National Fabrication Facility

12.6.7.   AI Fluidics PTY LTD

12.6.8.   Merck Pty. Ltd.

12.6.9.   Thermo Fisher Scientific Inc.

13.  Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions


Rising prevalence of chronic diseases, along with growing adoption of technological advancements are expected to drive Australia microfluidics market during forecast period.


Australia microfluidics market is segmented into product type, material, application, end user, company, and country.


Based on material type, the polymer segment is expected to hold the largest share in Australia microfluidics market during forecast period. This is attributed to the low cost, transparent, biocompatible, and well-established fabrication procedures.


Major companies operating in Australia microfluidics market include MTPConnect, SCHOTT AG, Microfluidics Biomedical Pty. Ltd., SDR Scientific Pty Ltd, WHITE RABBIT SCIENTIFIC LIMITED, Australian National Fabrication Facility, AI Fluidics PTY LTD, Merck Pty. Ltd., and Thermo Fisher Scientific Inc.


Sakshi Bajaal

Business Consultant
Press Release

Australia Microfluidics Market to Undergo Significant Growth Through 2025

Jul, 2020

Technological advancements and development of microfluidic 3D lab-on-a-chip devices to drive Australia microfluidics market